Update : 1
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Fri, 19 Sep 2008 06:51:25 -0500 (CDT)
Subject: What's New at CBER Update
You are subscribed to What's New at CBER for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.
Supplement Approval: Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant (Gardasil) - Statistical
Review and Evaluation
Posted: 9/18/2008
Update : 2
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Fri, 19 Sep 2008 07:57:12 -0500 (CDT)
Subject: CDER New 9/18/2008
|
September 18, 2008
- Covidien and Mallinckrodt Inc. inform healthcare professionals of important new safety information in prescribing Phosphocol P 32. MedWatch Safety Information
- Drug Shortages: Current Drug Shortages; Ammonul (sodium phenylacetate and sodium benzoate) Injection 10%/10%
- Drugs Shortages: Drugs to be Discontinued: Mitozytrex (Mitomycin for Injection)
- FDA releases its fourth issue of the FDA Drug Safety Newsletter
- International Conference on Harmonization (ICH) Public Meeting, October 21, 2008, Rockville, Maryland: Meeting information and registration
- List of Drugs Manufactured at the Dewas and Paonta Sahib Facilities of Ranbaxy Laboratories, Ltd. (updated)
- New and Generic Drug Approvals
- Amiodarone Hydrochloride Tablets, Zydus Pharmaceuticals USA Inc., Approval
- Glucovance (glyburide and metformin hydrochloride) Tablets, Bristol-Myers Squibb Co., Labeling Revision
- Keflex (cephalexin) Capsules, MiddleBrook Pharmaceuticals, Labeling Revision
- Proair HFA (albuterol sulfate) Inhalation Aerosol, Teva Global Regulatory Research, LLC, Patient Population Altered
- Protriptyline Hydrochloride Tablets, Roxane Laboratories, Inc., Approval
Update : 3
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Fri, 19 Sep 2008 08:07:42 -0500 (CDT)
Subject: U.S. Food & Drug Administration (FDA) CBER's Proposed and Final Rules Update
You are subscribed to CBER's Proposed and Final Rules for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.
FEDERAL REGISTER: FDA Regulations; Technical Amendment; Final Rule; Correction - 9/19/2008
Update : 4
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Fri, 19 Sep 2008 08:20:49 -0500 (CDT)
Subject: CDRH New Update
FDA Home Page | CDRH Home Page | Search | A-Z Index | ||
Date: September 19, 2008 |
The following new items were added to the CDRH web pages on September 18, 2008. Previous CDRH New Items can be found on the CDRHNew Page.
Update : 5
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Fri, 19 Sep 2008 10:05:13 -0500 (CDT)
Subject: What's New at CBER Update
You are subscribed to What's New at CBER for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.
FEDERAL REGISTER: FDA Regulations; Technical Amendment; Final Rule; Correction - 9/19/2008
Public Workshop: Structured Product Labeling Content of Labeling and Electronic Drug Establishment Registration and Drug Listing for the Biologics Industry
Posted: 9/19/2008
Update : 6
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Fri, 19 Sep 2008 11:06:51 -0500 (CDT)
Subject: What's New at CBER Update
You are subscribed to What's New at CBER for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.
Vacancy Announcement - Biologist/Lead/Supv Biologist
Posted: 9/19/2008
Vacancy Announcement - Microbiologist /Lead /Supv Microbiologist
Posted: 9/19/2008
Update : 7
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Fri, 19 Sep 2008 14:23:45 -0500 (CDT)
Subject: CDER New 7/19/2008
|
September 19, 2008
- New and Generic Drug Approvals
- Carbidopa and Levodopa Orally Disintegrating Tablets, Mylan Pharmaceuticals, Inc., Approval
- Celexa (citalopram hydrobromide) Oral Solution, Forest Laboratories, Inc., Labeling Revision
- Celexa (citalopram hydrobromide) Tablets, Forest Laboratories, Inc., Labeling Revision
- Epirubicin Hydrochloride Injection, Activis Totowa, LLC, Approval
- Lexapro (escitalopram oxalate) Oral Solution, Forest Laboratories, Inc., Labeling Revision
- Lexapro (escitalopram oxalate) Tablets, Forest Laboratories, Inc., Labeling Revision
- Ziprasidone Hydrochloride Capsules, Sandoz, Inc., Tentative Approval
Update : 8
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Fri, 19 Sep 2008 19:43:46 -0500 (CDT)
Subject: The FDA this Week: Andy's Take -- FDA: Listening and Leading: How We Promote and Protect Your Health
The FDA this Week: Andy's Take -- FDA: Listening and Leading: How We Promote and Protect Your Health
Fri, 19 Sep 2008 20:52:00 -0500
Welcome to Andy's Take. I'm Susan Winckler, FDA's Chief of Staff, and I am pleased to bring you this week's edition. In a typical week, you may hear many news reports that mention the FDA. Those reports provide a brief snapshot of FDA work on your behalf.
My Take is that depending on your interest, you may only have seen one of those many snapshots this week—or many reports about just one topic. And those reports might not have explained where FDA was in our decision-making process. Here's a recap of some of our work this week, where we were listening, clarifying, leading, educating, and taking action, as we assess the science about the food and medical products you use on a daily basis.
Update : 9
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Fri, 19 Sep 2008 14:02:37 -0500 (CDT)
Subject: Derringer Foodservices Issues Allergy Alert on Albacore Tuna Salad Hoagie (September 17)
Derringer Foodservices Issues Allergy Alert on Albacore Tuna Salad Hoagie (September 17)
Fri, 19 Sep 2008 13:31:00 -0500
This product is being recalled due to the omission of egg in the ingredient statement following the ingredient Reduced Calorie Mayonnaise. The recall decision was based on a potential allergen was included in the product and excluded from the label ingredient statement. This label omission was discovered in a standard ingredient statement audit.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420